Gracey Craig 4/A

What Happened

• Gracey Craig, Chief Accounting Officer of Omada Health (OMDA), exercised a total of 4,167 option-derived shares and immediately sold those shares in same-day transactions.
• On 2026-06-26 she exercised 2,084 shares at $6.57 each (cost $13,692) and sold them at $20.00 each for $41,680. On 2026-06-29 she exercised 2,083 shares at $6.57 each (cost $13,685) and sold them at $21.00 each for $43,743. Total exercised = 4,167 shares (total cost ~$27,377); total sale proceeds ≈ $85,423.
• The filing shows corresponding derivative entries (exercise/conversion) with $0 to reflect the extinguishment of the options as part of the exercise-and-sale.

Key Details

• Transaction dates & prices:
  • 2026-06-26: exercised 2,084 @ $6.57; sold 2,084 @ $20.00.
  • 2026-06-29: exercised 2,083 @ $6.57; sold 2,083 @ $21.00.
• Total: 4,167 shares exercised; ~$27,377 paid to exercise; ~$85,423 proceeds from sales.
• Sales were executed pursuant to a 10b5-1 trading plan adopted March 13, 2026 (footnote F2).
• This is an amended Form 4/A filed 2026-07-08 to restate the original 6/30/2026 Form 4 and to report the omitted exercise transactions; the original filing had timely reported the sales (footnote F1). Box 5 (beneficial ownership) was adjusted to correct an understatement.
• Vesting note: the underlying option vests 25% after the first anniversary from 9/9/2024, then monthly (1/48th) thereafter; fully vested after four years (footnote F3).

Context

• These were same-day exercise-and-sale (cashless-style) transactions: the options were exercised and the resulting shares were promptly sold, so this is generally a liquidity/compensation event rather than a straightforward buy signal.
• The use of a 10b5-1 plan indicates the sales were pre-arranged and not necessarily reflective of a new view on company prospects.
• The amendment corrects reporting of the exercises; investors should note the correction but not infer additional undisclosed trading.